Quantitation of Muscle Mass and Muscle Protein Synthesis Rate: Documenting a Response to Myoblast Transfer
The goal of treatment in muscular dystrophy is to provide a favorable effect on the natural history of muscle strength. Such an effect can be produced by improvement in strength, by arrest of progression, or by slowing in the rate of progression. All laboratory measurements which assess muscle histology or electrophysiology, muscle mass, or measure muscle components in serum (e.g. creatine kinase) are indirect and of value in a therapeutic trial only to the extent that they either predict or substantiate a clinical response. If myoblast transfer treatment is to be used, it will be studied initially in one muscle or at most, a small number of individual muscles. There is currently no documented way of establishing a change in the natural history of strength for individual muscles in Duchenne dystrophy. Indirect, laboratory measures of “success” of myoblast transfer treatment applied to individual muscles are therefore of potential importance since they may: (1) predict the ultimate clinical success of the treatment; (2) establish a mechanism of action for myoblast transfer; (3) provide clues as to other approaches which could be combined with myoblast transfer to improve results.
KeywordsMuscle Mass Muscular Dystrophy Duchenne Dystrophy Muscle Protein Synthesis Duchenne Muscular Dystrophy
Unable to display preview. Download preview PDF.
- 9.Griggs, R. C., Pandya, S., Florence, J. M., Brooke, M. H., et al,1989, Randomized controlled trial of testosterone in myotonic dystrophy. Neurol, 39: 219.Google Scholar
- 11.Jozefowicz, R. J., Ceckler, T. L., Flood, D. G., Herr, B. E.,Hawthorne, B. W., Griggs, R. C., 1989, Assessment of regional muscle volume utilizing forearm magnetic resonance imaging, Neurol, 39 (Suppl 1): 134.Google Scholar
- 12.Halliday, D., McKeran, R. 0., 1975, Measurement of muscle protein synthesis rate from serial muscle biopsies and total body protein rnover in many by continuous intravenous infusion of L-[alphaN]lysine, Clin Sci Molec Med, 49: 581.Google Scholar
- 15.Moxley, R. T., 1983, Metabolic studies in muscular dystrophy and their relationship to clinical pathophysiology: A focus upon myotonic dystrophy and Duchenne muscular dystrophy, Seminars Neurol, 3: 308.Google Scholar
- 17.Shengraw, R. E., Stuart, C. A., Prince, M. J., Peters, E. J., Wolfe, R. R. 1988, Insulin responsiveness of protein metabolism in vivo following bedrest in humans, Am J Physiol, 255: E548.Google Scholar